Kelly Lawrence W & Associates’s Bristol-Myers Squibb BMY Stock Holding History

Kelly Lawrence W & Associates’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-32	Closed	-$2K	–	176
2022 Q2	$2K	Buy	+32	New	+$2.44K	﹤0.01%	165
2019 Q1	–	Sell	-350	Closed	-$18K	–	129
2018 Q4	$18K	Hold	350	–	–	﹤0.01%	118
2018 Q3	$22K	Hold	350	–	–	﹤0.01%	122
2018 Q2	$19K	Hold	350	–	–	﹤0.01%	124
2018 Q1	$22K	Hold	350	–	–	﹤0.01%	125
2017 Q4	$21K	Buy	+350	New	+$21.9K	﹤0.01%	138
2016 Q4	–	Sell	-199,315	Closed	-$10.7M	–	161
2016 Q3	$10.7M	Buy	199,315 +163,315	+454%	+$10.5M	2.3%	19
2016 Q2	$2.65M	Buy	36,000 +32,000	+800%	+$2.26M	0.61%	40
2016 Q1	$256K	Hold	4,000	–	–	0.06%	80
2015 Q4	$276K	Sell	4,000 -600	-13%	-$39.6K	0.06%	78
2015 Q3	$273K	Sell	4,600 -2,142	-32%	-$136K	0.06%	78
2015 Q2	$448K	Sell	6,742 -25	-0.4%	-$1.65K	0.09%	65
2015 Q1	$437K	Sell	6,767 -263	-4%	-$16.5K	0.09%	61
2014 Q4	$415K	Sell	7,030 -175	-2%	-$9.87K	0.09%	64
2014 Q3	$369K	Hold	7,205	–	–	0.08%	65
2014 Q2	$349K	Hold	7,205	–	–	0.07%	69
2014 Q1	$374K	Sell	7,205 -82	-1%	-$4.36K	0.09%	65
2013 Q4	$387K	Sell	7,287 -1,000	-12%	-$50.9K	0.09%	67
2013 Q3	$383K	Sell	8,287 -83	-1%	-$3.64K	0.09%	64
2013 Q2	$374K	Buy	+8,370	New	+$363K	0.1%	66

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Kelly Lawrence W & Associates's BMY Position: Q3 2022 in Review

Kelly Lawrence W & Associates sold out of Bristol-Myers Squibb (BMY) in Q3 2022, closing a stake of 32 shares — an estimated $2K sold.

Kelly Lawrence W & Associates first reported a position in BMY in Q2 2013 and held it in 20 quarters. The position peaked at $10.7M in Q3 2016. 2,470 funds tracked by Wall St. Rank hold BMY as of Q3 2022.

Kelly Lawrence W & Associates reported no remaining Bristol-Myers Squibb position as of Q3 2022 after selling out during the quarter.
Kelly Lawrence W & Associates sold 32 Bristol-Myers Squibb shares in Q3 2022, an estimated $2K.
Kelly Lawrence W & Associates first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 20 quarters.
Kelly Lawrence W & Associates's Bristol-Myers Squibb position peaked at $10.7M in Q3 2016.
2,470 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.

Based on Kelly Lawrence W & Associates's 13F filing for Q3 2022, filed 15 Nov 2022.